Related Articles
The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma
Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway
Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels
Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line
Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts